152 related articles for article (PubMed ID: 34626910)
1. Opium use as an independent risk factor for pancreatic cancer: A case-control study.
Naghibzadeh-Tahami A; Marzban M; Yazdi-Feyzabadi V; Khazaei Z; Zahedi MJ; Moazed V; Haghdoost AA
Cancer Epidemiol; 2021 Dec; 75():102017. PubMed ID: 34626910
[TBL] [Abstract][Full Text] [Related]
2. Is opium use associated with an increased risk of lung cancer? A case-control study.
Naghibzadeh-Tahami A; Marzban M; Yazdi-Feyzabadi V; Dabiri S; Mohseni S; Abbasi Rayeni R; Samareh Fekri M; Larizadeh MH; Karimpour B; Khanjani N
BMC Cancer; 2020 Aug; 20(1):807. PubMed ID: 32842991
[TBL] [Abstract][Full Text] [Related]
3. Opium and Cigarette Smoking are Independently Associated with Bladder Cancer: The Findings of a Matched Case - Control Study.
Abdolahinia Z; Pakmanesh H; Mirzaee M; Bazrafshan A; Shafiei Bafti M; Shahesmaeili A
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3385-3391. PubMed ID: 34711016
[TBL] [Abstract][Full Text] [Related]
4. Opium use, cigarette smoking, and alcohol consumption in relation to pancreatic cancer.
Shakeri R; Kamangar F; Mohamadnejad M; Tabrizi R; Zamani F; Mohamadkhani A; Nikfam S; Nikmanesh A; Sotoudeh M; Sotoudehmanesh R; Shahbazkhani B; Ostovaneh MR; Islami F; Poustchi H; Boffetta P; Malekzadeh R; Pourshams A
Medicine (Baltimore); 2016 Jul; 95(28):e3922. PubMed ID: 27428185
[TBL] [Abstract][Full Text] [Related]
5. Opium as a risk factor for upper gastrointestinal cancers: a population-based case-control study in Iran.
Naghibzadeh Tahami A; Khanjani N; Yazdi Feyzabadi V; Varzandeh M; Haghdoost AA
Arch Iran Med; 2014 Jan; 17(1):2-6. PubMed ID: 24444058
[TBL] [Abstract][Full Text] [Related]
6. Opium Use and Head and Neck Cancers: A Matched Case-Control Study in Iran.
Alizadeh H; Naghibzadeh Tahami A; Khanjani N; Yazdi-Feyzabadi V; Eslami H; Borhaninejad V; Larizadeh MH; Enhesari A; Abbasi-Rayeni R; Moazed V; Arabi Mianroodi A
Asian Pac J Cancer Prev; 2020 Mar; 21(3):783-790. PubMed ID: 32212808
[TBL] [Abstract][Full Text] [Related]
7. Opium Use and the Risk of Cataract: a Hospital-based, Group-matched, Case-control Study in Iran.
Mehmandoost S; Sharifi A; Tohidinik HR; Shafa S; Hayati N; Sharifi M; McFarland W; Sharifi H
Ophthalmic Epidemiol; 2023 Feb; 30(1):66-73. PubMed ID: 35081859
[TBL] [Abstract][Full Text] [Related]
8. Opium and risk of gastrointestinal cancer: a case-control study.
Vazirinejad R; Najafipour R; Rezaeian M; Ghazizadeh A; Doost Mohammadi F
Turk J Med Sci; 2020 Jun; 50(4):697-705. PubMed ID: 32041383
[TBL] [Abstract][Full Text] [Related]
9. Opium as a Risk Factor for Bladder Cancer: A Population-based Case-control Study in Iran.
Akbari M; Naghibzadeh-Tahami A; Khanjani N; Baneshi MR; Kamali E; Hesampour M; Nazemzadegan B; Haghdoost AA
Arch Iran Med; 2015 Sep; 18(9):567-71. PubMed ID: 26317596
[TBL] [Abstract][Full Text] [Related]
10. Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran.
Hadji M; Rashidian H; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Mohebbi E; Safari-Faramani R; Seyyedsalehi MS; Hosseini B; Bakhshi M; Alizadeh-Navaei R; Ahmadi L; Rezaianzadeh A; Moradi A; Ansari-Moghaddam A; Nejatizadeh A; ShahidSales S; Zohrabi F; Mohammadi R; Nowroozi MR; Poustchi H; Nasrollahzadeh D; Najafi F; Haghdoost AA; Rahimi-Movaghar A; Etemadi A; Mohagheghi MA; Malekzadeh R; Brennan P; Schüz J; Boffetta P; Weiderpass E; Kamangar F; Zendehdel K; Pukkala E
Int J Epidemiol; 2022 Jun; 51(3):830-838. PubMed ID: 35244716
[TBL] [Abstract][Full Text] [Related]
11. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study.
Moossavi S; Mohamadnejad M; Pourshams A; Poustchi H; Islami F; Sharafkhah M; Mirminachi B; Nasseri-Moghaddam S; Semnani S; Shakeri R; Etemadi A; Merat S; Khoshnia M; Dawsey SM; Pharoah PD; Brennan P; Abnet CC; Boffetta P; Kamangar F; Malekzadeh R
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):268-273. PubMed ID: 29263189
[No Abstract] [Full Text] [Related]
12. Opium Use and the Risk of Liver Cancer: A Case-Control Study.
Marzban M; Mohebbi E; Haghdoost A; Aryaie M; Zahedi MJ; Khazaei Z; Gholizade M; Naghibzadeh-Tahami A
Cancer Prev Res (Phila); 2023 Jan; 16(1):29-35. PubMed ID: 36149933
[TBL] [Abstract][Full Text] [Related]
13. Cigarette Smoking and Opium Use in Relation to the Oral Microbiota in Iran.
Wu Z; Han Y; Caporaso JG; Bokulich N; Mohamadkhani A; Moayyedkazemi A; Hua X; Kamangar F; Wan Y; Suman S; Zhu B; Hutchinson A; Dagnall C; Jones K; Hicks B; Shi J; Malekzadeh R; Abnet CC; Pourshams A; Vogtmann E
Microbiol Spectr; 2021 Oct; 9(2):e0013821. PubMed ID: 34523990
[TBL] [Abstract][Full Text] [Related]
14. Opium use and risk of lung cancer: A multicenter case-control study in Iran.
Rashidian H; Hadji M; Gholipour M; Naghibzadeh-Tahami A; Marzban M; Mohebbi E; Safari-Faramani R; Bakhshi M; Sadat Seyyedsalehi M; Hosseini B; Alizadeh-Navaei R; Emami H; Haghdoost AA; Rezaianzadeh A; Moradi A; Ansari-Moghaddam A; Nejatizadeh A; ShahidSales S; Rezvani A; Larizadeh MH; Najafi F; Poustchi H; Mohagheghi MA; Brennan P; Weiderpass E; Schüz J; Pukkala E; Freedman ND; Boffetta P; Malekzadeh R; Etemadi A; Rahimi-Movaghar A; Kamangar F; Zendehdel K
Int J Cancer; 2023 Jan; 152(2):203-213. PubMed ID: 36043555
[TBL] [Abstract][Full Text] [Related]
15. Opium could be considered an independent risk factor for lung cancer: a case-control study.
Masjedi MR; Naghan PA; Taslimi S; Yousefifard M; Ebrahimi SM; Khosravi A; Karimi S; Hosseini M; Mortaz E
Respiration; 2013; 85(2):112-8. PubMed ID: 22759984
[TBL] [Abstract][Full Text] [Related]
16. Opium use and risk of colorectal cancer: a multi-center case-referent study in Iran.
Hadji M; Marzban M; Rashidian H; Naghibzadeh-Tahami A; Gholipour M; Mohebbi E; Safari-Faramani R; Seyyedsalehi MS; Hosseini B; Alizadeh-Navaei R; Rezaianzadeh A; Moradi A; ShahidSales S; Najafi F; Moazed V; Haghdoost AA; Rahimi-Movaghar A; Etemadi A; Malekzadeh R; Boffetta P; Weiderpass E; Kamangar F; Zendehdel K; Pukkala E
Acta Oncol; 2023 Dec; 62(12):1661-1668. PubMed ID: 37934078
[TBL] [Abstract][Full Text] [Related]
17. Smoking Water-Pipe, Opium Use and Prevalence of Heart Disease: A Cross-sectional Analysis of Baseline Data from the Pars Cohort Study, Southern Iran.
Adib A; Masoompour SM; Molavi Vardanjani H; Gondomkar A; Poustchi H; Salehi A; Islami F; Malekzadeh R
Arch Iran Med; 2020 May; 23(5):289-295. PubMed ID: 32383612
[TBL] [Abstract][Full Text] [Related]
18. Opium as a risk factor for early-onset coronary artery disease: Results from the Milano-Iran (MIran) study.
Maino A; Sadeghian S; Mancini I; Abbasi SH; Poorhosseini H; Boroumand MA; Lotfi-Tokaldany M; Jalali A; Pagliari MT; Rosendaal FR; Peyvandi F
PLoS One; 2023; 18(4):e0283707. PubMed ID: 37074987
[TBL] [Abstract][Full Text] [Related]
19. Diabetes Mellitus, Obesity, and Risk of Pancreatic Ductal Adenocarcinoma: a Large Case-Control Study from Iran.
Momayez Sanat Z; Masoudi S; Mansouri M; Ghamarzad Shishavan N; Jameshorani M; Pourshams A
Middle East J Dig Dis; 2021 Jan; 13(1):15-20. PubMed ID: 34712433
[TBL] [Abstract][Full Text] [Related]
20. Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
Sheikh M; Masoudi S; Bakhshandeh R; Moayyedkazemi A; Zamani F; Nikfam S; Mansouri M; Shishavan NG; Nikeghbalian S; Brennan P; Malekzadeh R; Pourshams A
PLoS One; 2020; 15(12):e0243511. PubMed ID: 33275621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
